Dr. Angel Guzman-Perez is the head of drug discovery at Scorpion Therapeutics, bringing extensive medicinal chemistry, drug discovery, and leadership experience. Prior to joining Scorpion, Dr. Guzman-Perez held leadership roles in Amgen’s research organization, serving as Executive Director, Head of Medicinal Chemistry and was responsible for the small-molecule portfolio across therapeutic areas. Previously, Dr. Guzman-Perez spent 14 years at Pfizer, holding roles of increasing seniority in the Cardiovascular and Metabolic Diseases Medicinal Chemistry group. Dr. Guzman-Perez has co-authored more than 50 peer-reviewed publications, been a co-inventor on more than 20 patents and contributed to the advancement of more than 20 compounds to pre-clinical development.
Dr. Guzman-Perez received his Ph.D. in chemistry from Harvard University working with E. J. Corey and focusing on enantioselective organic synthesis.
Sign up to view 0 direct reports
Get started